Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM ESTCompany ParticipantsPeter Dannenbaum - Vice ...
Akeso has a validated process in place for developing antibodies but does require US exposure to meet its lofty valuation.
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the ...
Penguins assistant coach Mike Stothers is a hockey lifer. A first-round draft pick of the Flyers, he played 10-plus seasons of professional hockey in the AHL and NHL in the 1980s and 90s before ...
Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more ...
Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...
Zacks Investment Research on MSN

Here's Why Merck (MRK) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
One of the teams is trying to combine mRNA vaccine with ultrasound technology to treat deadly pancreatic cancer.
The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...
Over the past two years, Merck ( MRK 0.19%) has faced several challenges, resulting in a decline in the company's share price ...